Scott L. Burrows

Companies

• Aeglea BioTherapeuticsChief financial officer Sep 5, 2023 to now¹
• Arcutis Biotherapeutics, Inc.Chief financial officer Apr 5, 2021 to Mar 8, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ABAeglea BioTherapeutics SYRE79,762 shares³$6.8M at $85.57Sep 2, 2026
• ABArcutis Biotherapeutics, Inc. ARQT59,115 shares⁴$1.9M at $32.50Mar 6, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 2, 2026Sold 18,232 shares at $89.35 of Aeglea BioTherapeutics³
• Sep 1, 2026Sold 200 shares at $89.04 of Aeglea BioTherapeutics³
• Sep 1, 2026Sold 2,016 shares at $88.03 of Aeglea BioTherapeutics³
• Sep 1, 2026Sold 4,384 shares at $87.11 of Aeglea BioTherapeutics³
• Sep 1, 2026Sold 900 shares at $86.25 of Aeglea BioTherapeutics³
• Sep 1, 2026Exercised options 7,500 shares at $14.50 of Aeglea BioTherapeutics³
• Aug 3, 2026Sold 100 shares at $97.10 of Aeglea BioTherapeutics⁵
• Aug 3, 2026Sold 2,300 shares at $96.30 of Aeglea BioTherapeutics⁵
• Aug 3, 2026Sold 5,100 shares at $95.21 of Aeglea BioTherapeutics⁵
• Aug 3, 2026Exercised options 7,500 shares at $14.50 of Aeglea BioTherapeutics⁵
• Jul 1, 2026Sold 1,725 shares at $88.37 of Aeglea BioTherapeutics⁶
• Jul 1, 2026Sold 5,775 shares at $87.55 of Aeglea BioTherapeutics⁶
• Jul 1, 2026Exercised options 7,500 shares at $14.50 of Aeglea BioTherapeutics⁶
• Jun 25, 2026Sold 10,000 shares at $87.14 of Aeglea BioTherapeutics⁷
• Jun 25, 2026Sold 5,000 shares at $87.12 of Aeglea BioTherapeutics⁷
• Jun 25, 2026Exercised options 15,000 shares at $14.50 of Aeglea BioTherapeutics⁷
• Jun 1, 2026Sold 3,100 shares at $72.06 of Aeglea BioTherapeutics⁸
• Jun 1, 2026Sold 2,599 shares at $70.77 of Aeglea BioTherapeutics⁸
• Jun 1, 2026Sold 1,801 shares at $69.75 of Aeglea BioTherapeutics⁸
• Jun 1, 2026Exercised options 7,500 shares at $14.50 of Aeglea BioTherapeutics⁸
• May 1, 2026Sold 12,500 shares at $71.37 of Aeglea BioTherapeutics⁹
• May 1, 2026Exercised options 12,500 shares at $14.50 of Aeglea BioTherapeutics⁹
• Apr 1, 2026Sold 1,300 shares at $49.98 of Aeglea BioTherapeutics¹⁰
• Apr 1, 2026Sold 6,200 shares at $49.21 of Aeglea BioTherapeutics¹⁰
• Apr 1, 2026Exercised options 7,500 shares at $14.50 of Aeglea BioTherapeutics¹⁰